No Data
Bitcoin Gets Closer to $100k Than Ever | Wall Street Today
Bitcoin Breaks Above $90k, Market Flat Wednesday | Live Stock
Texas Instruments and Other Overlooked Dividend Aristocrat Stocks -- Barrons.com
Disease activity improved by over 70%. johnson & johnson (JNJ.US) potential blockbuster monoclonal antibody recognized as a breakthrough therapy.
Johnson & Johnson (JNJ.US) announced recently that the US FDA has granted Breakthrough Therapy Designation (BTD) to its investigational antibody therapy nipocalimab targeting the neonatal Fc receptor (FcRn), for the treatment of adult patients with moderate to severe primary Sjögren's syndrome.
J&J Sues HHS Over 340B Hospital Drug-discount Program
J&J Sues U.S. Over Hospital Drug-Discounting Program -- WSJ
Money Thrill : Very good overview and diversification